Rocket Pharmaceuticals Inc. Company
Rocket Pharmaceuticals is an emerging biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. The Company’s lead program is a lentiviral-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure andpotentially cancer.
Industry:
Genomic and Epigenominc Instabillity
Headquarters:
United States
Register and Claim Ownership